EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Easy Oligonucleotide Platform for Rapid, Post-Isolation EV Modification: Dual-Function Uptake Control and Enhanced Targeting

Christopher G Blum, Shan Ying, Huda Usman, Phil G Campbell, Tagbo Niepa iD, Elizabeth Ransey, Jonathan E Henninger, Subha R Das iD

ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10209-10219

DOI: 10.1021/acsabm.6c01051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 19.10.2026. Verfasst von Christopher G Blum und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, and Center for Nucleic Acids Science & Technology, Carnegie Mellon University, Pittsburgh, Pennsylvania15213, United States. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Extracellular Vesicles, Biocompatible Materials, Oligodeoxyribonucleotides. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) hold immense therapeutic potential, yet their clinical translation is hindered by nonspecific cellular uptake and the complexity and cost of surface engineering. Here, we present the EZON (Easy OligoNucleotide) EV modification platform, a cost-effective, post-isolation modification system that addresses both limitations simultaneously. The EZON platform employs unmodified DNA aptamers that bind directly to tetraspanin proteins on EV surfaces, eliminating the need for cholesterol conjugation, covalent chemistry, or genetic engineering of producer cells. EVs are thus easily and rapidly functionalized in a single incubation step at substantially reduced oligonucleotide cost. The EZON platform enables dual functionality: (1) the oligonucleotide anchor (ONA) sequence inhibits nonspecific cellular uptake, while (2) the display strand enables targeted delivery through ligand-mediated internalization. We demonstrate that our optimized ONA construct efficiently functionalizes EVs from multiple mammalian cell types. Cancer cells selectively internalized EZON-modified EVs functionalized with AS1411, an aptamer that targets nucleolin, whereas off-target internalization was suppressed. The platform’s versatility extends to protein display via histidine-tag aptamers and therapeutic cargo delivery, as demonstrated by targeted doxorubicin delivery to head and neck squamous cell carcinoma cells. This rapid, modular approach transforms unmodified EVs into precision delivery vehicles within hours, offering a scalable solution for targeted therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideExtracellular VesiclesBiocompatible MaterialsOligodeoxyribonucleotidesOligonucleotidesHumansMaterials TestingParticle SizeDoxorubicin

Stichwörter der Autor:innen

DNAaptamerdrug deliveryexosomeextracellular vesiclemembrane engineering

Substanzen

Aptamers, NucleotideBiocompatible MaterialsOligodeoxyribonucleotidesOligonucleotidesAGRO 100Doxorubicin

Autor:innen und Institutionen

  • Department of Chemistry, and Center for Nucleic Acids Science & Technology, Carnegie Mellon University, Pittsburgh, Pennsylvania15213, United States.
  • Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania15213, United States.
  • Department of Chemical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania15213, United States.
  • Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania15213, United States.

ORCID-Profile: Tagbo Niepa, Subha R Das

Zitieren

APA

Blum, C. G., Ying, S., Usman, H., Campbell, P. G., Niepa, T., Ransey, E., Henninger, J. E., & Das, S. R. (2026). An Easy Oligonucleotide Platform for Rapid, Post-Isolation EV Modification: Dual-Function Uptake Control and Enhanced Targeting. ACS Applied Bio Materials, 9(21), 10209-10219. https://doi.org/10.1021/acsabm.6c01051

Vancouver

Blum CG, Ying S, Usman H, Campbell PG, Niepa T, Ransey E, et al. An Easy Oligonucleotide Platform for Rapid, Post-Isolation EV Modification: Dual-Function Uptake Control and Enhanced Targeting. ACS Applied Bio Materials. 2026;9(21):10209-10219. doi:10.1021/acsabm.6c01051

BibTeX
@article{Blum2026,
  author = {Blum, Christopher G and Ying, Shan and Usman, Huda and Campbell, Phil G and Niepa, Tagbo and Ransey, Elizabeth and Henninger, Jonathan E and Das, Subha R},
  title = {An Easy Oligonucleotide Platform for Rapid, Post-Isolation EV Modification: Dual-Function Uptake Control and Enhanced Targeting},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  volume = {9},
  number = {21},
  pages = {10209--10219},
  doi = {10.1021/acsabm.6c01051}
}
Kostenlos starten →